BG Medicine Compliant With NASDAQ Listing Requirements

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., March 11, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) (the “Company”) today announced that it has received correspondence from The NASDAQ Stock Market LLC (“NASDAQ”) confirming that the Company has evidenced compliance with the requirements for continued listing on The NASDAQ Capital Market. Accordingly, the NASDAQ compliance matter has been closed.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC